Elucidating the Neuroprotective Effect of Tecoma stans Leaf Extract in STZ-Induced Diabetic Neuropathy

• Published in: Evidence-based complementary and alternative medicine 2022, Vol.2022, p.1-13
• Main Authors: Gupta, Amit, Behl, Tapan, Sehgal, Aayush, Singh, Sukhbir, Sharma, Neelam, Yadav, Shivam, Anwer, Khalid, Cruz, Celia Vargas-De-La, Chigurupati, Sridevi, Farasani, Abdullah, Bhatia, Saurabh
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animal models; Anti-inflammatory agents; Antidiabetics; Biochemical analysis; Cancer; Carotenoids; Diabetes; Diabetes mellitus; Diabetic neuropathy; Dosage; Drug dosages; Flavonoids; Gabapentin; Glucose; Inflammation; Laboratory animals; Leaves; Metabolic disorders; Neuroprotection; Parameter estimation; Pharmaceuticals; Pharmacy; Plant extracts; Statistical analysis; Streptozocin; Tecoma stans; Transmissible spongiform encephalopathy
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2022/3833392

Background. Diabetes is considered one of the most encyclopedic metabolic disorders owing to an alarming rise in the number of patients, which is increasing at an exponential rate. With the current therapeutics, which only aims to provide symptomatic and momentary relief, the scientists are shifting gears to explore alternative therapies which not only can target diabetes but can also help in limiting the progression of diabetic complications including diabetic neuropathy (DN). Methods. Tecoma stans leaf methanolic extract was prepared using the Soxhlet method. A streptozotocin (STZ; 45 mg/kg)-induced diabetic animal model was used and treatment with oral dosing of T. stans leaf extract at the different doses of 200 mg/kg, 300 mg/kg, and highest dose, i.e., 400 mg/kg, was initiated on day 3 after STZ administration. The pharmacological response for general and biochemical (angiogenic, inflammatory, and oxidative) parameters and behavioral parameters were compared using Gabapentin as a standard drug with the results from the test drug. Results. Parameters associated with the pathogenesis of diabetic neuropathy were evaluated. For general parameters, different doses of T. stans extract (TSE) on blood sugar showed significant effects as compared to the diabetic group. Also, the results from biochemical analysis and behavioral parameters showed significant positive effects in line with general parameters. The combination therapy of TSE at 400 mg/kg with a standard drug produced nonsignificant effects in comparison with the normal group. Conclusion. The leaves of T. stans possess antidiabetic effects along with promising effects in the management of DN by producing significant effects by exhibiting antioxidative, antiangiogenic, and anti-inflammatory properties, which are prognostic markers for DN, and thus, T. stans can be considered as an emerging therapeutic option for DN.